P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FRO...

por Mai, E. K., Bertsch, U., Fenk, R., Tichy, D., Besemer, B., Dürig, J., Schroers, R., von Metzler, I., Hänel, M., Mann, C., Asemissen, A. M., Heilmeier, B., Nievergall, E., Huhn, S., Kriegsmann, K., Weinhold, N., Luntz, S., Holderrried, T. A. W., Trautmann-Grill, K., Gezer, D., Klaiber-Hakimi, M., Müller, M., Khandanpour, C., Knauf, W., Scheid, C., Munder, M., Geer, T., Riesenberg, H., Thomalla, J., Hoffmann, M., Raab, M. S., Salwender, H. J., Weisel, K. C., Goldschmidt, H.
Publicado 2022

Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer

por Mountzios, G., Samantas, E., Senghas, K., Zervas, E., Krisam, J., Samitas, K., Bozorgmehr, F., Kuon, J., Agelaki, S., Baka, S., Athanasiadis, I., Gaissmaier, L., Elshiaty, M., Daniello, L., Christopoulou, A., Pentheroudakis, G., Lianos, E., Linardou, H., Kriegsmann, K., Kosmidis, P., El Shafie, R., Kriegsmann, M., Psyrri, A., Andreadis, C., Fountzilas, E., Heussel, C.-P., Herth, F.J., Winter, H., Emmanouilides, C., Oikonomopoulos, G., Meister, M., Muley, T., Bischoff, H., Saridaki, Z., Razis, E., Perdikouri, E.-I., Stenzinger, A., Boukovinas, I., Reck, M., Syrigos, K., Thomas, M., Christopoulos, P.
Publicado 2021